Liu, Xiaojun

Multiplex genome editing to generate universal CAR T cells resistant to PD1 inhibition

Ren, J., Liu, X., Fang, C., Jiang, S., June, C. H., & Zhao, Y. (2017) · Clinical Cancer Research

CAR-T cell therapy researchCRISPR and Genetic Engineering

Cited by 942

Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells

Fraietta, J. A., Nobles, C. L., Sammons, M. A., Lundh, S., Carty, S. A., Reich, T. J., Cogdill, A. P., Morrissette, J. J. D., DeNizio, J. E., Reddy, S., et al. (2018) · Nature

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 862

Platelet to lymphocyte ratio is associated with the severity of coronary artery disease and clinical outcomes of percutaneous coronary intervention in the Chinese Han population

Zhou, D., Wang, G., Fan, Y., Wan, Z., & Liu, X. (2017) · Experimental and Therapeutic Medicine

Inflammatory Biomarkers in Disease PrognosisLipoproteins and Cardiovascular Health

Cited by 40